ABBV
Price:
$216.63
Market Cap:
$382.74B
AbbVie Inc. is a global biopharmaceutical company dedicated to the discovery, development, manufacturing, and commercialization of advanced medicines. Its extensive therapeutic portfolio encompasses several key areas: Immunology and Inflammation: Leading products include HUMIRA, an injectable therapy for autoimmune and intestinal Behçet's diseases; SKYRIZI, which addresses moderate to severe plaque psoriasis in adults; and RINVOQ, a JAK inhibitor for moderate to severe active rheumatoid arthritis in adult patients. Oncology and Hematology: For blood cancers, AbbVie provides IMBRUVICA and VENCLEXTA (a BCL-2 inhibitor), both indicated for adult patients with chronic lymphocytic leukemia (CLL) ...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2013-01-02
Stock Exchange
NYSE
Ticker
ABBV
According to AbbVie Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 446.21B. This represents a change of -0.07% compared to the average of 446.51B of the last 4 quarters.
The mean historical Enterprise Value of AbbVie Inc. over the last ten years is 272.36B. The current 446.21B Enterprise Value has changed 16.28% with respect to the historical average. Over the past ten years (40 quarters), ABBV's Enterprise Value was at its highest in in the September 2025 quarter at 473.40B. The Enterprise Value was at its lowest in in the December 2016 quarter at 131.47B.
Average
272.36B
Median
282.36B
Minimum
133.31B
Maximum
470.64B
Discovering the peaks and valleys of AbbVie Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 62.51%
Maximum Annual Enterprise Value = 470.64B
Minimum Annual Increase = -9.59%
Minimum Annual Enterprise Value = 133.31B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 470.64B | 24.95% |
| 2024 | 376.67B | 17.24% |
| 2023 | 321.29B | -5.83% |
| 2022 | 341.20B | 10.96% |
| 2021 | 307.49B | 19.54% |
| 2020 | 257.23B | 62.51% |
| 2019 | 158.29B | -9.59% |
| 2018 | 175.09B | -4.02% |
| 2017 | 182.41B | 36.83% |
| 2016 | 133.31B | 11.52% |
The current Enterprise Value of AbbVie Inc. (ABBV) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
389.53B
5-year avg
363.46B
10-year avg
272.36B
AbbVie Inc.’s Enterprise Value is less than Johnson & Johnson (583.08B), greater than AstraZeneca PLC (297.92B), greater than Novartis AG (320.16B), less than Novo Nordisk A/S (1.43T), greater than Merck & Co., Inc. (325.03B), greater than UnitedHealth Group Incorporated (414.05B), greater than Amgen Inc. (227.49B), greater than Gilead Sciences, Inc. (168.20B), greater than Pfizer Inc. (206.49B), greater than Sanofi (103.60B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 583.08B | $549.78B | |
| 297.92B | $271.29B | |
| 320.16B | $280.64B | |
| 1.43T | $191.93B | |
| 325.03B | $281.24B | |
| 414.05B | $364.13B | |
| 227.49B | $182.21B | |
| 168.20B | $153.66B | |
| 206.49B | $143.74B | |
| 103.60B | $101.89B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AbbVie Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AbbVie Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is AbbVie Inc.'s Enterprise Value?
What is the highest Enterprise Value for AbbVie Inc. (ABBV)?
What is the 3-year average Enterprise Value for AbbVie Inc. (ABBV)?
What is the 5-year average Enterprise Value for AbbVie Inc. (ABBV)?
How does the current Enterprise Value for AbbVie Inc. (ABBV) compare to its historical average?